| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that could disrupt protein degradation pathways regulated by ZYG11A, affecting its functional role in cell cycle control. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits proteasome activity, potentially impacting the degradation of substrates targeted by ZYG11A in the cell cycle regulation process. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin, as a proteasome inhibitor, may alter the turnover of proteins regulated by ZYG11A, affecting cell cycle progression. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Ixazomib, by inhibiting the proteasome, could impact the degradation of cell cycle regulators targeted by ZYG11A. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Oprozomib inhibits proteasome activity, potentially affecting the function of ZYG11A in the ubiquitin-proteasome pathway. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $175.00 $600.00 $1179.00 $5100.00 $9180.00 | 26 | |
Oligomycin A inhibits mitochondrial ATP synthase, potentially affecting cellular energy status and indirectly influencing ZYG11A's role in the cell cycle. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis, potentially affecting the production and turnover of proteins like ZYG11A in the cell cycle regulation process. | ||||||